PATENT CLAIM ANALYSIS

Application Number: 15933076
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["514", "184000"]

Abstract:
Platinum(II) complexes with various selones (L) having the general formula PtL 2 Cl 2  are disclosed. The platinum(II) complexes of the invention inhibit growth of cancer cells in vitro and are useful for treatment of proliferative disorders such as cancers and/or tumors.

Claim (Index 9):
The pharmaceutical composition of  claim 8 , wherein the pharmaceutically acceptable carrier and/or excipient is at least one selected from the group consisting of a buffer, an inorganic salt, a fatty acid, a vegetable oil, a synthetic fatty ester, a surfactant, and a polymer.

Metadata:
- Claim Count in Document: 47.0
- Percentile: 90.0
- Lexical Diversity: 1.3
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15864650', '14854225', '15794384', '15008889', '15715964']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8050629679602269
- 35 USC 102 Novelty (BERT): 0.5050140004081265
- Combined Prediction Score: 0.7750580712050168
- Mean Citation Score: 249.220958
- Max Citation Score: 290.38693
- Similarity Product: 237.07225066388847

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test